Direxion Daily S&P Biotech Bear 3X ETF (LABD) Declines 1.72% for Sep 17

September 17, 2017 - By Richard Conner

Sep 17 is a negative day so far for Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD) as the ETF is active during the day after losing 1.72% to hit $5.13 per share. The exchange traded fund has net assets and 9.79% volatility this month.

Over the course of the day 902,752 shares traded hands, as compared to an average volume of 3.54M over the last 30 days for Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD).

The ETF is -85.89% of its 52-Week High and 3.54% of its low, and is currently having ATR of 2.56. This year’s performance is -52.98% while this quarter’s performance is -31.36%.

The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.

More notable recent Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA:LABD) news were published by: Investorplace.com which released: “Direxion Daily S&P Biotech Bear 3X Shares (LABD): The Quick Guide to LABD” on May 08, 2017, also Quotes.Wsj.com with their article: “Direxion Daily S&P Biotech Bear 3X Shares” published on May 29, 2015, Realmoney.Thestreet.com published: “This Correction Could Gain Some Traction” on July 05, 2017. More interesting news about Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA:LABD) were released by: Investorplace.com and their article: “Be Careful Before Loving Leveraged Biotech ETFs” published on October 06, 2015 as well as Etfdailynews.com‘s news article titled: “Triple Leveraged Biotech Fund Sees Massive Outflows As Biotech Cools (LABU)” with publication date: September 06, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.